|

Ramipril Clinical Trials

3 actively recruiting trials

Also known as: ACE inhibitor

Pipeline

Phase 3: 2Phase 4: 1

Top Sponsors

  • Sherief Abd-Elsalam1
  • John Paul II Hospital, Krakow1
  • Evi Liliek Wulandari1

Indications

  • Heart Disease2
  • Liver Fibroses1
  • Heart Failure with Moderately Reduced Ejection Fraction1
  • Heart Failure With Reduced Ejection Fraction (HFrEF)1
  • Liver Disease1

Other3 trials

Effect of Some Drugs on Liver Fibrosis
Phase 3
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
Phase 4
The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.